The presence of tumor DNA in CSF was first reported in 1995 by Harker Rhodes et al, who used allele specific PCR to detect tumor‐derived p53 DNA in the CSF of a glioblastoma patient (Harker Rhodes et al, 1995). This evidence concerns the gene TP53 and neoplasm.